List of Excipients in API halobetasol propionate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing halobetasol propionate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER COPOLYMER TYPE B | |
Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER HOMOPOLYMER TYPE A | |
Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | DIETHYL SEBACATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing halobetasol propionate
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | CETYL ALCOHOL |
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | DIAZOLIDINYL UREA |
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | GLYCERIN |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for halobetasol propionate
Excipient focus: ALCOHOL
halobetasol propionate drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma | halobetasol propionate | 51862-604 |
Mayne Pharma | halobetasol propionate | 51862-606 |
Mayne Pharma | halobetasol propionate | 68308-769 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: ALLYL PENTAERYTHRITOL
halobetasol propionate drug variants containing ALLYL PENTAERYTHRITOL
Company | Ingredient | NDC |
---|---|---|
Teligent Pharma Inc | halobetasol propionate | 52565-073 |
McKesson Corporation | halobetasol propionate | 63739-998 |
Sola Pharmaceuticals | halobetasol propionate ointment | 70512-033 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ALLYL PENTAERYTHRITOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM STEARATE
halobetasol propionate drug variants containing ALUMINUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ALUMINUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZOIC ACID
halobetasol propionate drug variants containing BENZOIC ACID
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma | halobetasol propionate | 51862-604 |
Mayne Pharma | halobetasol propionate | 51862-606 |
Mayne Pharma | halobetasol propionate | 68308-769 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing BENZOIC ACID
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLPARABEN
halobetasol propionate drug variants containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER COPOLYMER TYPE B
halobetasol propionate drug variants containing CARBOMER COPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER COPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
halobetasol propionate drug variants containing CARBOMER HOMOPOLYMER TYPE A
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER HOMOPOLYMER TYPE A
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
halobetasol propionate drug variants containing CARBOMER HOMOPOLYMER TYPE C
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: CETETH-20
halobetasol propionate drug variants containing CETETH-20
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CETETH-20
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
halobetasol propionate drug variants containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma | halobetasol propionate | 51862-604 |
Mayne Pharma | halobetasol propionate | 51862-606 |
Mayne Pharma | halobetasol propionate | 68308-769 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
halobetasol propionate drug variants containing CETYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CETYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: DIAZOLIDINYL UREA
halobetasol propionate drug variants containing DIAZOLIDINYL UREA
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing DIAZOLIDINYL UREA
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: DIETHYL SEBACATE
halobetasol propionate drug variants containing DIETHYL SEBACATE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing DIETHYL SEBACATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: DIISOPROPYL ADIPATE
halobetasol propionate drug variants containing DIISOPROPYL ADIPATE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing DIISOPROPYL ADIPATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
halobetasol propionate drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
halobetasol propionate drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ISOSTEARATE
halobetasol propionate drug variants containing ISOPROPYL ISOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1321 |
Bryant Ranch Prepack | halobetasol propionate | 63629-8735 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ISOPROPYL ISOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
halobetasol propionate drug variants containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
halobetasol propionate drug variants containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLCHLOROISOTHIAZOLINONE
halobetasol propionate drug variants containing METHYLCHLOROISOTHIAZOLINONE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-129 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing METHYLCHLOROISOTHIAZOLINONE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLISOTHIAZOLINONE
halobetasol propionate drug variants containing METHYLISOTHIAZOLINONE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing METHYLISOTHIAZOLINONE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
halobetasol propionate drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: MONOSTEARYL CITRATE
halobetasol propionate drug variants containing MONOSTEARYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1322 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing MONOSTEARYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: OCTYLDODECANOL
halobetasol propionate drug variants containing OCTYLDODECANOL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing OCTYLDODECANOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: PENTAERYTHRITOL
halobetasol propionate drug variants containing PENTAERYTHRITOL
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
QUAGEN PHARMACEUTICALS LLC | halobetasol propionate | 70752-119 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing PENTAERYTHRITOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
halobetasol propionate drug variants containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: POLAWAX POLYSORBATE
halobetasol propionate drug variants containing POLAWAX POLYSORBATE
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma | halobetasol propionate | 51862-604 |
Mayne Pharma | halobetasol propionate | 51862-606 |
Mayne Pharma | halobetasol propionate | 68308-769 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLAWAX POLYSORBATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
halobetasol propionate drug variants containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
halobetasol propionate drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
Company | Ingredient | NDC |
---|---|---|
Mayne Pharma | halobetasol propionate | 51862-604 |
Mayne Pharma | halobetasol propionate | 51862-606 |
Mayne Pharma | halobetasol propionate | 68308-769 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
halobetasol propionate drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
halobetasol propionate drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
halobetasol propionate drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOOLEATE
halobetasol propionate drug variants containing SORBITAN MONOOLEATE
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SORBITAN MONOOLEATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN SESQUIOLEATE
halobetasol propionate drug variants containing SORBITAN SESQUIOLEATE
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SORBITAN SESQUIOLEATE
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
halobetasol propionate drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARETH-21
halobetasol propionate drug variants containing STEARETH-21
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-129 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing STEARETH-21
Company | Ingredient | NDC |
---|---|---|
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
halobetasol propionate drug variants containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
halobetasol propionate drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
>Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
halobetasol propionate drug variants containing WHITE WAX
Company | Ingredient | NDC |
---|---|---|
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1322 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing WHITE WAX
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
>Company | >Ingredient | >NDC |
Excipient focus: YELLOW WAX
halobetasol propionate drug variants containing YELLOW WAX
Company | Ingredient | NDC |
---|---|---|
Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
Teligent Pharma Inc | halobetasol propionate | 52565-073 |
HJ Harkins Company Inc | halobetasol propionate | 52959-961 |
>Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing YELLOW WAX
Company | Ingredient | NDC |
---|---|---|
Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
Bausch Health US LLC | halobetasol propionate | 0187-0002 |
Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.